{"text": ["FDA", "Approves", "BAVENCIO\u00ae", "(avelumab)", "Plus", "INLYTA\u00ae", "(axitinib)", "Combination", "for", "Patients", "with", "Advanced", "Renal", "Cell", "Carcinoma"], "created_at": "2019-05-14 23:44:00"}
{"text": ["Generic", "Drugmakers", "Face", "Antitrust", "Suit", "Alleging", "Price", "Fixing"], "created_at": "2019-05-14 15:17:19"}
{"text": ["Generic", "Drugmakers", "Face", "Antitrust", "Suit", "Alleging", "Price", "Fixing"], "created_at": "2019-05-14 15:17:19"}
{"text": ["Health", "Care", "Sector", "Update", "for", "05/14/2019:", "CTST,", "KMDA,", "MNK,", "JNJ,", "PFE,", "ABT,", "MRK,", "AMGN"], "created_at": "2019-05-14 13:46:57"}
{"text": ["Health", "Care", "Sector", "Update", "for", "05/14/2019:", "CTST,", "KMDA,", "MNK,", "JNJ,", "PFE,", "ABT,", "MRK,", "AMGN"], "created_at": "2019-05-14 13:46:57"}
{"text": ["Generic", "Drugmakers", "Face", "Antitrust", "Suit", "Alleging", "Price", "Fixing"], "created_at": "2019-05-14 13:18:01"}
